Because there tends to be mutual exclusivity between ARID4B and PTEN deletions in prostate cancer genome (Supplementary Table 3), ARID4B might be a synthetic-essential gene for prostate tumorigenesis in the context of PTEN deficiency. Here, ARID4B is linked to prostate carcinoma.